Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Medhat M Said

3PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Dec 23, 2025
Model-informed precision dosing of carboplatin in cancer patients by leveraging myelosuppression data from electronic health records.

Alessandro De Carlo, Elena Maria Tosca, Mirjam Crul

|Feb 22, 2025
Disease-Drug-Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic Analysis.

Medhat M Said, Job R Schippers, Leila Atmowihardjo

|Mar 11, 2023
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?

Medhat M Said, Martinus P G Broen, Eleonora L Swart

Pageof 1

Frequent Collaborators

3 joint publications

Imke H Bartelink

2 joint publications

Eleonora L Swart

1 joint publications

Martinus P G Broen

1 joint publications

Mathilde C M Kouwenhoven

1 joint publications

Job R Schippers

1 joint publications

Leila Atmowihardjo

1 joint publications

Yingxue Li

1 joint publications

Mick S van der Plas

1 joint publications

Harm J Bogaard

1 joint publications

Lieuwe D J Bos

Frequent Collaborators

3 joint publications

Imke H Bartelink

2 joint publications

Eleonora L Swart

1 joint publications

Martinus P G Broen

1 joint publications

Mathilde C M Kouwenhoven

Top Related Videos

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>
08:41

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Published on : Feb 09, 2016

9.5K
A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.1K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on : Feb 16, 2015

21.5K
See more related videos

Top Related Videos

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>
08:41

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Published on : Feb 09, 2016

9.5K
A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.1K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on : Feb 16, 2015

21.5K
See more related videos